On Tuesday, a bill was passed by the Oregon House that would establish some cancers, including multiple myeloma, as job-related for firefighters.  Under state compensation law, the bill will require cities in Oregon to cover cancer treatment for firefighters.

Even though firefighters wear protective gear, they are still exposed to many carcinogens each time they enter a burning building.

Thus, the bill requires coverage of 12 types of cancer: brain, colon, stomach, testicular, prostate, multiple myeloma, …

The Leukemia & Lymphoma Society (LLS) and Women’s Running magazine will hold a women’s half marathon in St. Petersburg, FL, during the weekend of November 21-22.

The event, titled Women's Running St. Pete Half Marathon to benefit The Leukemia & Lymphoma Society, is expected to draw women from all over the country.

Participants can either train to run or walk through LLS’s Team in Training (TNT), the world’s first and largest charity sports training program. Through …

Bag Ladies Luncheon – The Leukemia & Lymphoma Society (LLS) will hold the Bag Ladies Luncheon on February 5 at Golden Ocala Golf & Equestrian Club in Ocala, FL. This event allows guests to enjoy a luncheon while shopping for new designer handbags and gently-used celebrity handbags at a live auction. For more information, visit the LLS Web site.

Bachelors For Cures – The Leukemia & Lymphoma Society (LLS) will host Bachelor’s for Cures to raise money …

Dress Down Day For Leukemia & Lymphoma Society – On January 30, the Leukemia & Lymphoma Society (LLS) invites employees in companies across Western New York, with approval from their employers, to dress in their favorite casual attire. For a $5 donation, employees will support families and patients of leukemia, lymphoma, Hodgkin's disease, and myeloma. For more information, please visit the LLS Web site.

Current Trends In Leukemia, Lymphoma, And Myeloma – The conferences will …

The multi-center randomized Phase 3 double-blind clinical trial of Zolinza (vorinostat) or placebo in combination with Velcade (bortezomib) will be opening soon. The study will be conducted under Dr. Sundar Jagannath, Chief of the Multiple Myeloma Program at St. Vincent’s Comprehensive Cancer Center in New York.

In combination with the recently announced Phase 2B open-label clinical trial of Velcade plus Zolinza, Dr. Jagannath hopes that this Phase 3 trial will help to explore the effects of combining …

The health care system in the United Kingdom is making more treatment options available to terminally ill patients.

In England and Wales, the National Institute for Health and Clinical Excellence (NICE) decides which treatments will be made available under the state-funded National Health Service.  Until recently, NICE refused to approve the use of any drug costing more than £30,000 ($44,000) for each extra year of good health attributable to the drug.

On January 2, NICE issued new guidelines to approve, …

According to a study by the American Cancer Society Cancer Action Network (ACS CAN) and Avalere Health, Medicare beneficiaries will be paying more out of their own pockets for cancer therapies in the upcoming year. They will also have more restrictions on access to cancer drugs than they have had in the past. The ACS and Avalere analysis was based on data for about 4,500 Medicare prescription drug plans.

In 2009, most Medicare prescription drug plans will place cancer drugs, …